Author:
May Thomas,Evans James P.
Abstract
AbstractIn this paper, we ask whether or not we can afford to realize the potential benefits of genetic testing as a screening tool for adoptees. Our method is to provide reasonable cost and savings estimates. We argue that the prospect of cost neutrality should be sufficient to explore the targeted screening for a population who will otherwise suffer an avoidable health disparity in access to inherited disease information. Our goal here is to establish that the investment needed to attain these benefits is not beyond our means.
Publisher
Cambridge University Press (CUP)
Reference47 articles.
1. Watson, B (2013) Breast cancer gene: why most women can’t do what Angelina Jolie did. aol.com Finance, https://www.aol.com/2013/05/15/angelina-jolie-breast-cancer-gene-cost/
2. The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates
3. Health Costhelper (NDa) http://health.costhelper.com/mammogram.html [9 November 2018].
4. NCCN Guidelines (ND) https://nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf [9 November 2018].
5. Does Lack of “Genetic-Relative Family Health History” Represent a Potentially Avoidable Health Disparity for Adoptees?
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献